Status:
RECRUITING
Real Life Data From Hypertensive Patients Treated With Renal Denervation in Current Practice in France- French RENal Denervation Registry
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Hypertension (HTN)
Eligibility:
All Genders
18+ years
Brief Summary
Renal denervation (RDN) is a recent procedure that can be used to control BP (blood pressure) in hypertensive patients. Numerous publications from randomised trials have demonstrated the efficacy of R...
Detailed Description
This study concerns patients with high blood pressure who have been treated with renal denervation since January 2010 or who will undergo renal denervation after March 2025.
Eligibility Criteria
Inclusion
- Adult ( \> 18 years old) hypertensive patients treated with RDN in France whatever the catheter and the indication. This might include retrospective data for patient already treated with RDN in the past.
Exclusion
- RDN not proposed to the patient, patient opposing the collection and use of his/her data for research purposes.
Key Trial Info
Start Date :
June 23 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07206030
Start Date
June 23 2025
End Date
October 1 2028
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Grenoble Alpes
La Tronche, France, France, 38700